Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population

Completed

Conditions studied: HIV Infections

In brief

This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in pediatric subjects who are between 12 and 17 years of age. A minimum of ten (10) known HIV-positive participants will be tested.

Key facts

Study ID
NCT00567749
Run by
Chembio Diagnostic Systems, Inc.
People needed
10
Starts
2007-12-01
Expected to finish
2008-06-01
Last updated by the study team
2008-06-27

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.